Cochrane review1Anti-inflammatory gels and creams for long-term muscle and joint pain
Who and when. A Cochrane pain research team at the University of Oxford, published April 2016.
What they did. They pooled 39 double-blind randomised trials with 10,631 people, almost all with knee arthritis, that compared an anti-inflammatory gel, cream or patch with a plain one or with tablets. Trials ran for 6 to 12 weeks.
What they found. About 60 percent of people using diclofenac or ketoprofen gel had much less pain, but so did about half of those using a plain gel. For every 10 people using diclofenac gel, 1 got a good result they would not have had with a plain gel. For ketoprofen it was 1 in 7. Few trials compared gels with tablets, but those that did found similar relief. Diclofenac gel caused more mild skin reactions than a plain gel. Serious side effects were rare.
What it means. Gels help a minority of people, and much of the relief comes from the act of rubbing something in. They are a safe first thing to try, with far fewer stomach and heart risks than tablets.
Derry S, Conaghan P, Da Silva JAP, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016;4(4):CD007400.
Read the summary on PubMed →
International guideline2OARSI guideline for non-surgical treatment of knee and hip osteoarthritis
Who and when. The Osteoarthritis Research Society International, the main scientific body for arthritis research, published July 2019.
What they did. A panel of 21 experts from 11 countries reviewed the pooled trial evidence for 60 different treatments and voted on each one.
What they found. Anti-inflammatory gels were strongly recommended for knee arthritis (the top level, 1A) for everyone, including people with stomach, heart or kidney problems who should avoid anti-inflammatory tablets.
What it means. This is the first medicine the OARSI panel suggests for knee arthritis, ahead of tablets.
Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA, Kraus VB, Lohmander LS, Abbott JH, Bhandari M, Blanco FJ, Espinosa R, Haugen IK, Lin J, Mandl LA, Moilanen E, Nakamura N, Snyder-Mackler L, Trojian T, Underwood M, McAlindon TE. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578-1589.
Read the summary on PubMed →
US guideline3American College of Rheumatology guideline for osteoarthritis
Who and when. The American College of Rheumatology and the Arthritis Foundation, published January 2020. The panel included patients as well as doctors and therapists.
What they did. A literature review team summarised the benefits and harms of every common treatment, and a voting panel graded each recommendation as strong or conditional.
What they found. Anti-inflammatory gels received a strong recommendation for knee arthritis, and the panel advised trying them before tablets, especially in people over 75.
What it means. Gel first, tablets second, is now standard advice.
Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D, Gellar K, Harvey WF, Hawker G, Herzig E, Kwoh CK, Nelson AE, Samuels J, Scanzello C, White D, Wise B, Altman RD, DiRenzo D, Fontanarosa J, Giradi G, Ishimori M, Misra D, Shah AA, Shmagel AK, Thoma LM, Turgunbaev M, Turner AS, Reston J. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2020;72(2):220-233.
Read the summary on PubMed →
UK guideline4NICE guideline on osteoarthritis in people over 16
Who and when. The National Institute for Health and Care Excellence, which sets standards for the NHS in England, published October 2022.
What they did. NICE committees review the evidence and the cost of each treatment before recommending it.
What they found. NICE recommends an anti-inflammatory gel as the first medicine to try for knee arthritis, before considering tablets. It advises against paracetamol and glucosamine as routine treatments.
What it means. The same gel-first approach as the American and international guidelines.
National Institute for Health and Care Excellence. Osteoarthritis in over 16s: diagnosis and management. NICE guideline NG226. London: NICE; 2022.
Read the guideline →
Australian guideline5RACGP guideline for knee and hip osteoarthritis
Who and when. The Royal Australian College of General Practitioners, with Australian arthritis researchers, second edition 2018. This is the guideline Australian GPs follow.
What they did. An expert panel reviewed the research on each treatment and graded how strongly to recommend it, for or against.
What they found. Anti-inflammatory gels are conditionally recommended for knee arthritis, for short-term use during flares.
What it means. Australian GPs are advised they are a reasonable option, with less strong backing than the overseas guidelines give.
Royal Australian College of General Practitioners. Guideline for the management of knee and hip osteoarthritis. 2nd ed. East Melbourne: RACGP; 2018.
Read the guideline →